Please Wait...

Overcoming Barriers to Risk Based Monitoring - On Demand Webinar

Speakers:

Mireille Zerola
Mireille Zerola,
Clinical Data
Management Expert, Boehringer Ingelheim

Courtney McBean
Courtney McBean,
Vice President of Clinical Innovation

Duration: 1 hour

Complete form below to view the on-demand webinar >>

Courtney McBean has over 15 years of experience as a clinical researcher and cross-functional business leader. Courtney has led teams responsible for clinical auditing, field monitoring, and biostatistics and developed corporate strategies for ensuring quality in the clinical trial process. Courtney is the co-creator of the award-winning Compass Intelligent Monitoring Solution.

Risk-Based Monitoring offers an amazing opportunity, but there are many companies that are hesitant to undertake such an initiative. In this interactive webinar, experts Mireille Zerola and Courtney McBean will discuss common challenges organizations face when transitioning to risk based monitoring and ways to overcome these obstacles.

Courtney and Mireille will hold a similar session on February 26th at the 2015 BioClinica European User Conference and will include their learnings from the conference session in this webinar.

The presentation will also include an overview of the role of technology in Risk-Based Monitoring and a demonstration of the Compass "Intelligent Monitoring" solution.

View all upcoming BioClinica webinars.

 

Please fill out the form below to view the On Demand Webinar.

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Bioclinica is divided into three business segments so that we can provide expert service and multifaceted technologies. Our Medical Imaging and Biomarkers segment includes an Imaging Core Lab, a Cardiovascular Safety division, and a Biomarker Laboratory. Our eHealth segment comprises an eClinical Solutions Division along with Safety and Regulatory Solutions. Under the Global Clinical Research segment, we offer a network of research sites, patient recruitment, and a Post-Approval Research division.

[Fun Friday] Now that's using you noodle! Ck this out in @RandDMagazine https://t.co/o5h9O1ScBF
bioclinica (7 hours ago)
FDA, NIH & Industry Advance Templates for Clinical Trial Protocols | RAPS https://t.co/Cqda7fLQZf
bioclinica (Yesterday)
Significant Safety Events Found in a Third of FDA-Approved Drugs, Study Finds | RAPS https://t.co/mAHe42W4or
bioclinica (Yesterday)
FDA Official Highlights Foreign Supply Chain Challenges | RAPS https://t.co/qHDtoRw9MS
bioclinica (Yesterday)
RT @MySCRS: Survey finds 50% of Americans are unaware of #ClinicalTrials, reported by @EdClinical. https://t.co/57x8gtXRT0
bioclinica (Yesterday)
RT @ACROhealth: Recent poll data from @ResearchAmerica, 59% of those polled said their family’s health has been improved by clinical resear…
bioclinica (Yesterday)

Latest Blogs: